Table 2 Availability (%) of essential medicines and technologies for NCDs at public secondary care facilities
Disease | Items based on NPCDCS guidelines | Community Health Centre | District Hospitals | ||||
|---|---|---|---|---|---|---|---|
NPCDCSa (n = 281) | Others (n = 105) | Total N = 415 | NPCDCSa (n = 290) | Others (n = 45) | Total N = 335 | ||
| Â | Availability (95% CI) | Â | |||||
Diabetes mellitus | Medicines - At least one of each - hypoglycemic agent and insulin | 55.2 (49.3–60.9) | 43.3 (35.1–51.8) | 51.3 (46.5–56.1) | 74.5 (69.1–79.2) | 73.3 (58.6–84.2) | 74.3 (69.4–78.7) |
Technologies - At least one of each - lancets. Glucometer, biochemical analyser, glucostrips, urine strips reagents/kits for glucose test and for lipid profile, centrifuge | 21.7 (17.3–26.9) | 13.4 (8.6–20.3) | 19.0 (15.5–23.1) | 50.3 (44.6–56.1) | 51.1 (36.8–65.3) | 50.4 (45.1–55.8) | |
Both medicines & technologies as defined above | 17.1 (13.1–22.0) | 9.0 (5.1–15.1) | 14.5 (11.4–18.2) | 42.1 (36.5–47.8) | 42.2 (28.8–56.9) | 42.1 (36.9–47.5) | |
Cardio-vascular diseases | Medicines - At least one each - ‘anti platelet agent, betablocker, long acting calcium channel blocker, ACE inhibitor, diuretic, nitrate, statin / lipid lowering medicines, medicines for shock and heart failure. | 39.9 (34.3–45.7) | 21.6 (15.5–29.4) | 34.0 (29.6–38.7) | 59.0 (53.2–64.5) | 62.2 (47.4–75.1) | 59.4 (54.0–64.5) |
Technologies - At least one of each - B.P. Apparatus, Stethoscope, Measuring Tape, weighing scale, Height scale, Cardiac Monitor, Defibrillator, ECG machine & Roll, 12 Channel stress ECG Tread Mill. | 1.1 (0.3–3.3) | 2.2 (0.7–6.7) | 1.4 (0.6–3.2) | 20.3 (16.1–25.4) | 11.1 (4.7–24.1) | 19.1 (15.2–23.7) | |
Both medicines & technologies as defined above | 1.1 (0.3–3.3) | 0.7 (0.1–5.1) | 1.0 (0.4–2.5) | 16.6 (12.7–21.3) | 8.9 (3.4–21.4) | 15.5 (12.0–19.8) | |
Chronic Respiratory Diseases | Medicines – At least one of each - Bronchodilator, a steroid inhalant. | 19.2 (15.0–24.3) | 17.9 (12.3–25.4) | 18.8 (15.3–22.9) | 36.6 (31.2–42.3) | 31.1 (19.3–45.9) | 35.8 (30.9–41.1) |
Technologies - At least one of each - Nebulizer and Pulse Oximeter. | 75.4 (70.1–80.1) | 61.9 (53.4–69.8) | 71.1 (66.5–75.3) | 94.5 (91.2–96.6) | 84.4 (70.8–92.4) | 93.1 (89.9–95.4) | |
Both medicines & technologies as defined above | 17.4 (13.4–22.3) | 15.7 (10.4–22.9) | 16.9 (13.6–20.8) | 35.2 (29.9–40.9) | 31.1 (19.3–45.9) | 34.6 (29.7–39.9) | |
All above NCDs | Medicines - Inclusive of above medicines for specific diseases | 13.2 (9.7–17.7) | 8.2 (4.6–14.2) | 11.6 (8.8–15.0) | 28.3 (23.4–33.7) | 22.2 (12.4–36.6) | 27.5 (22.9–32.5) |
Technologies - Inclusive of above technologies for specific diseases | 0.4 (0.0–2.5) | 0.7 (0.1–5.1) | 0.5 (0.1–1.9) | 14.5 (10.9–19.0) | 6.7 (2.2–18.8) | 13.4 (10.2–17.5) | |
Both medicines & technologies as defined above | 0.4 (0.0–2.5) | 0.7 (0.1–5.1) | 0.5 (0.1–1.9) | 14.5 (10.9–19.0) | 6.7 (2.2–18.8) | 13.4 (10.2–17.5) | |